Abstract: A method is implemented by a network device to dynamically optimize lookup speed in a packet processing table maintained at the network device while the network device is in operation. The method includes determining one or more runtime metrics of the packet processing table, selecting a lookup algorithm for the packet processing table from a set of lookup algorithms supported by the network device based on the one or more runtime metrics of the packet processing table, and configuring the network device to match incoming packets against rules in the packet processing table using the selected lookup algorithm for the packet processing table.

Abstract: A technique for status change handling in an interconnect node is described, wherein the node comprises a data plane that can assume, per service, a passive or active status. A method aspect in the node comprises transmitting, to another node, a first indication that a change has been or is about to be performed, awaiting, from the other node, reception of a second indication that the data plane in the other node has been set to the passive status, and activating, responsive to the received indication, the data plane of the node from the passive status to the active status. The method aspect in the other node further comprises receiving, from the node, the first indication, passivating, responsive to the receiving step, the data plane being in the active status to the passive status, and transmitting, upon completion of the passivating step, the second indication.

Abstract: Disclosed herein are stable complexes with controlled particle size, increased apparent solubility and increased dissolution rate comprising as active compound Celecoxib, its salts, or derivatives thereof, which is useful in the treatment of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, acute pain especially in cancer related acute pain, primary dysmenorrhea. More specifically, the complexes possess instantaneous redispersibility, increased apparent solubility and permeability that provide faster onset of action for acute pain relief and lower GI related side effects. Further disclosed are methods of formulating and manufacturing the complexes described herein, pharmaceutical compositions, and uses and methods of treatment.

Abstract: Disclosed herein are pharmaceutically acceptable complex formulations comprising complexes of Lumacaftor, or a salt, or derivative thereof together with complexation agents and, optionally, pharmaceutically acceptable excipients; processes for the preparation thereof and pharmaceutical compositions containing them. The complex formulations have improved dissolution and permeability in fasted and fed state simulation that is expected to deliver full absorption and the elimination of the food effect.

Abstract: Disclosed herein are stable complexes with controlled particle size, increased apparent solubility and increased dissolution rate comprising as active compound Celecoxib, its salts, or derivatives thereof, which is useful in the treatment of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, acute pain especially in cancer related acute pain, primary dysmenorrhea. More specifically, the complexes possess instantaneous redispersibility, increased apparent solubility and permeability that provide faster onset of action for acute pain relief and lower GI related side effects. Further disclosed are methods of formulating and manufacturing the complexes described herein, pharmaceutical compositions, and uses and methods of treatment.

Abstract: A system and method for bonding a protective cover to a mobile device is disclosed. A cold cast protective cover is permanently bonded to the device and provides protection against damage from dropping, impact, exposure to electric or static discharge, and exposure to liquid, gas, and dusts. The cold cast protective cover takes the shape around all or some desired portion of the outer surface of the mobile device while still providing access to the device's user interface, including display, power and volume buttons, power charging port, memory port, speaker port, camera lens, and the like. The cold cast protective cover can, with additives, increase the safety of the device for Intrinsic Safety or Hazardous environments.

Abstract: Disclosed herein are pharmaceutically acceptable complex formulations comprising complexes of Lumacaftor, or a salt, or derivative thereof together with complexation agents and, optionally, pharmaceutically acceptable excipients; processes for the preparation thereof and pharmaceutical compositions containing them. The complex formulations have improved dissolution and permeability in fasted and fed state simulation that is expected to deliver full absorption and the elimination of the food effect.

Abstract: A method is implemented by a network device to dynamically optimize lookup speed in a packet processing table maintained at the network device while the network device is in operation. The method includes determining one or more runtime metrics of the packet processing table, selecting a lookup algorithm for the packet processing table from a set of lookup algorithms supported by the network device based on the one or more runtime metrics of the packet processing table, and configuring the network device to match incoming packets against rules in the packet processing table using the selected lookup algorithm for the packet processing table.

Abstract: The invention relates to a counting unit (100) configured to count an amount of traffic events of a data packet traffic. The counting unit comprises a counting element (131) configured to store a value representing the amount of traffic events.

Abstract: Disclosed herein are stable complexes with controlled particle size, increased apparent solubility and increased dissolution rate comprising as active compound Celecoxib, its salts, or derivatives thereof, which is useful in the treatment of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, acute pain especially in cancer related acute pain, primary dysmenorrhea. More specifically, the complexes possess instantaneous redispersibility, increased apparent solubility and permeability that provide faster onset of action for acute pain relief and lower GI related side effects. Further disclosed are methods of formulating and manufacturing the complexes described herein, pharmaceutical compositions, and uses and methods of treatment.

Abstract: A method is implemented by a network device to dynamically optimize lookup speed in a packet processing table maintained at the network device while the network device is in operation. The method includes determining one or more runtime metrics of the packet processing table, selecting a lookup algorithm for the packet processing table from a set of lookup algorithms supported by the network device based on the one or more runtime metrics of the packet processing table, and configuring the network device to match incoming packets against rules in the packet processing table using the selected lookup algorithm for the packet processing table.

Abstract: A system and method for bonding a protective cover to a mobile device is disclosed. A cold cast protective cover is permanently bonded to the device and provides protection against damage from dropping, impact, exposure to electric or static discharge, and exposure to liquid, gas, and dusts. The cold cast protective cover takes the shape around all or some desired portion of the outer surface of the mobile device while still providing access to the device's user interface, including display, power and volume buttons, power charging port, memory port, speaker port, camera lens, and the like. The cold cast protective cover can, with additives, increase the safety of the device for Intrinsic Safety or Hazardous environments.

Abstract: The invention relates to a counting unit (100) configured to count an amount of traffic events of a data packet traffic. The counting unit comprises a counting element (131) configured to store a value representing the amount of traffic events.

Abstract: An oval lifting-body airplane may generate lift without wings. It may be propelled by a pivoting propulsion engine attached to an upper surface, allowing it to fly substantially parallel to the oval's major axis or the oval's minor axis, allowing different configurations for landing and takeoff than for cruising.

Abstract: A system and method for bonding a protective cover to a mobile device is disclosed. A cold cast protective cover is permanently bonded to the device and provides protection against damage from dropping, impact, exposure to electric or static discharge, and exposure to liquid, gas, and dusts. The cold cast protective cover takes the shape around all or some desired portion of the outer surface of the mobile device while still providing access to the device's user interface, including display, power and volume buttons, power charging port, memory port, speaker port, camera lens, and the like. The cold cast protective cover can, with additives, increase the safety of the device for Intrinsic Safety or Hazardous environments.

Abstract: Disclosed herein are stable complexes with controlled particle size, increased apparent solubility and increased dissolution rate comprising as active compound Celecoxib, its salts, or derivatives thereof, which is useful in the treatment of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, acute pain especially in cancer related acute pain, primary dysmenorrhea. More specifically, the complexes possess instantaneous redispersibility, increased apparent solubility and permeability that provide faster onset of action for acute pain relief and lower GI related side effects. Further disclosed are methods of formulating and manufacturing the complexes described herein, pharmaceutical compositions, and uses and methods of treatment.

Abstract: A method is implemented by a network device to dynamically optimize lookup speed in a packet processing table maintained at the network device while the network device is in operation. The method includes determining one or more runtime metrics of the packet processing table, selecting a lookup algorithm for the packet processing table from a set of lookup algorithms supported by the network device based on the one or more runtime metrics of the packet processing table, and configuring the network device to match incoming packets against rules in the packet processing table using the selected lookup algorithm for the packet processing table.

Abstract: Disclosed herein are pharmaceutically acceptable complex formulations comprising complexes of Lumacaftor, or a salt, or derivative thereof together with complexation agents and, optionally, pharmaceutically acceptable excipients; processes for the preparation thereof and pharmaceutical compositions containing them. The complex formulations have improved dissolution and permeability in fasted and fed state simulation that is expected to deliver full absorption and the elimination of the food effect.

Abstract: The present disclosure provides a technique for ensuring that a service or conversation is carried in a congruent manner on a Link Aggregation Group (LAG). The Service ID (e.g., conversation ID) to link mapping is configured on both sides of the LAG independently of each other. The Service ID to link assignment is stored in a well-defined format, e.g. in an assignment table. A digest is then prepared on the assignment table. The digest is exchanged between the two sides of the LAG. If there is a mismatch between the digests, then the service is transmitted on a predefined and agreed-upon default link if congruency has to be enforced for that particular service. Furthermore, the digest exchange allows verification on the configuration to check whether all services to be handed-off are configured on both sides.

Abstract: The invention is directed to a stable complex with controlled particle size, increased apparent solubility and increased dissolution rate comprising as active compound Sirolimus or derivatives thereof, which is useful in the prophylaxis of organ rejection in patients receiving renal transplants, in the treatment of psoriasis, facial angiofibromas associated with tuberous sclerosis, fibrofolliculomas found in Birt-Hogg-Dubé Syndrome, chronic erosive oral lichen planus, Early Stage Cutaneous T-cell Lymphoma, Treatment of Autoimmune Active Anterior Uveitis, dry eye syndrome, age-related macular degeneration, diabetic macular edema, noninfectious uveitis, telangiectasia, inflammatory skin diseases (dermatitis, including psoriasis and lichen ruber planus), Pachyonychia Congenita and in the suppression of angiogenesis pathways.